Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
BMJ ; 319(7214): 881-4, 1999 Oct 02.
Article in English | MEDLINE | ID: mdl-10506041

ABSTRACT

OBJECTIVE: To determine the efficacy of antibacterial prophylaxis in preventing infectious complications after percutaneous endoscopic gastrostomy. DESIGN: Prospective, randomised, placebo controlled, double blind, multicentre study. SETTING: Departments of internal medicine at six German hospitals. SUBJECTS: Of 106 randomised adult patients with dysphagia, 97 received study medication, and 84 completed the study. The median age of the patients was 65 years. Most had dysphagia due to malignant disease (65%), and many (76%) had serious comorbidity. INTERVENTIONS: A single intravenous 2.2 g dose of co-amoxiclav or identical appearing saline was given 30 min before percutaneous endoscopic gastrostomy performed by the thread pull method. MAIN OUTCOME MEASURES: Occurrence of peristomal wound infections and other infections within one week after percutaneous endoscopic gastrostomy. RESULTS: The incidence of peristomal and other infections within one week after percutaneous endoscopic gastrostomy was significantly reduced in the antibiotic group (8/41 (20%) v 28/43 (65%), P<0.001). Similar results were obtained in an intention to treat analysis. Several peristomal wound infections were of minor clinical significance. After wound infections that required no or only local treatment were excluded from the analysis, antibiotic prophylaxis remained highly effective in reducing clinically important wound infections (1/41 (2%) v 11/43 (26%), P<0.01) and non-wound infections (2 (5%) v 9 (21%), P<0.05). CONCLUSIONS: Antibiotic prophylaxis with a single dose of co-amoxiclav significantly reduces the risk of infectious complications after percutaneous endoscopic gastrostomy and should be recommended.


Subject(s)
Amoxicillin-Potassium Clavulanate Combination/administration & dosage , Antibiotic Prophylaxis , Deglutition Disorders/surgery , Drug Therapy, Combination/administration & dosage , Gastroscopy/methods , Gastrostomy/methods , Administration, Oral , Adult , Aged , Aged, 80 and over , Double-Blind Method , Humans , Middle Aged , Prospective Studies
2.
Pathologe ; 18(3): 252-6, 1997 May.
Article in German | MEDLINE | ID: mdl-9273545

ABSTRACT

The case of a 63-year-old man with a widespread retroperitoneal tumor and two tumor nodules in the left testis is described. Histopathological and cytopathological examination of tissue from the retroperitoneal tumor led to a diagnosis of lymphoreticular neoplasia. The patient died in acute cardiac failure, five weeks after initial presentation. Autopsy revealed another tumor nodule in the right atrium. Macroscopically, the bone marrow appeared normal. The tumor cells were reactive for CD45, vimentin and chloroacetate esterase, but were uncreative with a broad spectrum of antibodies against myelomonocytic and lymphocytic antigens and antibodies against tryptase and c-kit (CD117), characteristic markers for mast cells. However, the bone marrow exhibited the typical picture of mastocytosis. A diagnosis of bone marrow mastocytosis with an associated secondary extramedullary mast cell sarcoma was established. The cause of death was heart failure due to arrhythmia caused by an exophytic atrioseptal tumor nodule.


Subject(s)
Bone Marrow/pathology , Mast-Cell Sarcoma/pathology , Mastocytosis/pathology , Neoplasms, Multiple Primary/pathology , Retroperitoneal Neoplasms/pathology , Testicular Neoplasms/pathology , Biomarkers, Tumor/analysis , Carboxylic Ester Hydrolases/analysis , Heart Atria/pathology , Heart Neoplasms/pathology , Humans , Leukocyte Common Antigens/analysis , Male , Mast Cells/pathology , Middle Aged , Vimentin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...